Skip to content
★ Sign in to follow
HH

Hans Hull

Directeur Commercial
Pliant Therapeutics, Inc.Adverum Biotechnologies, Inc.
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
32
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€2.9M

Latest filing published 27 Jan 2025 for Pliant Therapeutics, INC..

Filing timeline

BuySale
Hans Hull

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

Hans Hull: trading record in brief

Hans Hull is a declared insider at 2 companies (senior executive); the most frequent names are Pliant Therapeutics, Inc. and Adverum Biotechnologies, Inc. We count 32 filings; the first trade dates from 5 August 2014 and the latest from 23 January 2025.

Sales make up the whole of the open-market record (13 sales, €2.9M). Outside the open market, there are 9 share grants and 7 option exercises. In 2025 alone, the filings show no purchases and 1 sale.

The record was last updated on 27 January 2025 with a share grant in Pliant Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Hans Hull

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations32 total

25 of 32 declarations